Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Downgrades Church & Dwight Co to Hold

Argus Research Downgrades Church & Dwight Co to Hold

Argus Research downgrades Church & Dwight Co (NYSE:CHD) from Buy to Hold.

byBenzinga Newsdesk

February 13, 2023

1 minute read

Argus Research downgrades Church & Dwight Co (NYSE:CHD) from Buy to Hold.

Morgan Stanley Maintains Overweight on Constellation Energy, Lowers Price Target to $101

By Benzinga Newsdesk

February 22, 10:49 AM

Morgan Stanley analyst Stephen Byrd maintains Constellation Energy (NASDAQ:CEG) with a Overweight and lowers the price target from $102 to $101.

CEG

Roblox Expands to Meta’s Quest VR Headsets, Brings Immersive Gaming to a Growing Community

By Anusuya Lahiri

July 13, 7:17 AM

Roblox Corp's (NYSE: RBLX) online game will

Realty Income Announces An Increase In The Company’s Common Stock Monthly Cash Dividend To $0.2565 Per Share From $0.2560 Per Share

By Benzinga Newsdesk

December 12, 5:13 PM

Realty Income Corporation ((Realty Income, NYSE:O), The Monthly Dividend Company®, today announced it has declared an increase in the company's common stock monthly cash dividend to $0.2565 per share from $0.2560

Pasithea Therapeutics Awarded $694K Drug Development Research Grant

By Bill Haddad

July 14, 8:06 AM

-- AUD $1 million (U.S $694,000) grant transferred as part of Alpha-5 Integrin, LLC transaction -- -- Provides approximately U.S. $694,000 of non-dilutive funding -- MIAMI BEACH, Fla., July 14, 2022 (GLOBE NEWSWIRE) --

KTTA

Argus Research Downgrades Church & Dwight Co to Hold

Related Posts

Morgan Stanley Maintains Overweight on Constellation Energy, Lowers Price Target to $101

Roblox Expands to Meta’s Quest VR Headsets, Brings Immersive Gaming to a Growing Community

Realty Income Announces An Increase In The Company’s Common Stock Monthly Cash Dividend To $0.2565 Per Share From $0.2560 Per Share

Pasithea Therapeutics Awarded $694K Drug Development Research Grant